EP Patent

EP4438124A3 — Methods for treating testicular and ovarian adrenal rest tumors

Assigned to Spruce Biosciences Inc · Expires 2024-12-18 · 1y expired

What this patent protects

Provided herein are compounds and pharmaceutical compositions for the prevention and treatment of testicular adrenal rest tumors (TART) or ovarian adrenal rest tumors (OART).

USPTO Abstract

Provided herein are compounds and pharmaceutical compositions for the prevention and treatment of testicular adrenal rest tumors (TART) or ovarian adrenal rest tumors (OART).

Drugs covered by this patent

Patent Metadata

Patent number
EP4438124A3
Jurisdiction
EP
Classification
—
Expires
2024-12-18
Drug substance claim
No
Drug product claim
No
Assignee
Spruce Biosciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.